跳至主要内容
临床试验/NCT02133703
NCT02133703已完成不适用

Decision Making Interventions for Women Receiving Uninformative BRCA1/2 Test Results or Positive BRCA1/2 Test Results

Georgetown University2 个研究点 分布在 1 个国家目标入组 369 人开始时间: 2015年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
369
试验地点
2
主要终点
Decision Satisfaction

研究概览

简要总结

This non-therapeutic trial is for women who have received results of genetic testing for BRCA1/2 mutations. The trial compares decision support tools designed to facilitate informed decision making regarding risk management following testing to usual care. The researchers will test separate decision support tools for women who receive positive test results and women who receive negative/inconclusive test results. Among women who receive a positive test result, an interactive decision support intervention will be compared to a print intervention. Among women who receive an inconclusive result, an interactive intervention will be compared to usual care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Undergo BRCA1/2 genetic counseling and testing at one of four study sites
  • Receive positive or uninformative test results
  • English speaking

排除标准

  • Newly diagnosed breast cancer patients who have not yet initiated definitive breast cancer treatment
  • Previous bilateral mastectomy

结局指标

主要结局

Decision Satisfaction

时间窗: 12-months post-randomization

Satisfaction with Decision Scale

Psychological Distress

时间窗: 1-month post randomization

Decision Conflict

时间窗: 1-month post-randomization

Decisional Conflict Scale

Knowledge

时间窗: 1-month post randomization

Knowledge of risk management options.

Health Related Quality of Life

时间窗: 12-months post randomization

SF-12

Utilization of breast and ovarian cancer risk management options

时间窗: 12-months post-randomization

We will assess uptake of the following risk management strategies: 1. Risk reducing surgery (mastectomy and oophorectomy) 2. Chemoprevention 3. Breast and ovarian cancer screening

次要结局

  • Knowledge(3-months post randomization)
  • Psychological Distress(3-months post-randomization)
  • Decisional Conflict(3-months post-randomization)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验